Q3
Predicted--
Actual$6.21
LLY
$1026.62
$19.16
( 1.83% )
Today
$1052.64
$1038.82
$1025.00
Earnings
Q2
Predicted--
Actual$6.29
Q1
Predicted--
Actual$3.06
Q4
Predicted--
Actual$4.88
LLY Key Statistics
Market Cap
951B
High Today
$1106.17
Low Today
$1023.96
Volume
3.54M
Open Price
$1077.09
52 Week High
$1132.87
52 Week Low
$623.78
Average Volume
43.6M
About LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Employees
47,000
Headquarters
INDIANAPOLIS, IN